← Back to Search

Single cohort of MS patients with EDSS 1.0-4.5 for Multiple Sclerosis (ETNA-MS Trial)

N/A
Recruiting
Research Sponsored by Innodem Neurosciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

ETNA-MS Trial Summary

The overarching goal of this research protocol is to validate the effectiveness of Innodem's ETNA-MS device in informing clinicians on the disability status of Multiple Sclerosis (MS) patients. Effectiveness of the device will be assessed by the level of agreement between the EDSS estimated by the device and the actual scores measured by the neurologist in-person assessments.

ETNA-MS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Validate the effectiveness of the ETNA-MS device to estimate MS disease severity/status as estimated by the EDSS.
Secondary outcome measures
Validate that the ETNA-MS device has good test-retest reliability for estimating the EDSS.
Validate the effectiveness of the ETNA-MS device to estimate the 9-Hole Peg Test (9-HPT) as part of the Multiple sclerosis functional composite (MSFC).
Validate the effectiveness of the ETNA-MS device to estimate the Brief Visuospatial Memory Test-Revised (BVMT-R) as part of the Brief International Cognitive Assessment for MS (BICAMS).
+3 more

ETNA-MS Trial Design

1Treatment groups
Experimental Treatment
Group I: Single cohort of MS patients with EDSS 1.0-4.5Experimental Treatment1 Intervention
Confirmed diagnosis of MS with an EDSS score ranging from 1.0 and 4.5.

Find a Location

Who is running the clinical trial?

Innodem NeurosciencesLead Sponsor
7 Previous Clinical Trials
1,288 Total Patients Enrolled
4 Trials studying Multiple Sclerosis
508 Patients Enrolled for Multiple Sclerosis
Syneos HealthOTHER
172 Previous Clinical Trials
68,394 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
206 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
ETNA-MS Device Validation Study
2023. "ETNA-MS Device Validation Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06256731.
All > Phoenix > Columbia
~10 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top